David O. Watson, General Counsel of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a biopharmaceutical company with a market capitalization of $3.75 billion, reported selling 2,201 shares of the company ...

the Company got into a Business Transfer Agreement for purchase of the business undertakings of Watson Pharma Private Limited through slump sale on a going concern basis costing Rs 46.8 Crores.In ...

Market OverviewThe Global Healthcare Analytics Market is valued at $33.80 Billion in the year 2022 and is forecasted to reach ...

Sarah Sheldon, an engineering physicist from IBM, talks to Joe McEntee about the company’s efforts to open up the next ...

Cognitive computers, such as IBM Watson ... the company will be ready, with a whole division dedicated to developing business models, experts and specialist products. The pharmaceutical industry ...

Part of this years House GOP legislative priorities focuses on bringing down health care costs. A House committee approved ...

On January 30, 2025, IBM Research hosted a tour at its Yorktown Heights headquarters, discussing the latest advancements in artificial intelligence (AI), quantum computing, semiconductor technology, ...

US markets bled hundreds of billions of dollars after the release of a revolutionary Chinese AI — but one company has emerged as the surprise ... said it was a ‘wake-up call’. Picture: Jim Watson/AFP ...

Bioxyne said the group expects to shortly receive ARTG Listing approval for the export of its Dr Watson Pharmaceutical products to the UK. The company is also completing a business case for ...